Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects

Psychopharmacology

Volumn 123, Issue 1, 1996, Pages 26-33

  Volkow, N D ^a,b   Wang, G J ^a   Gatley, S J ^a   Fowler, J S ^a   Ding, Y S ^a   Logan, J ^a   Hitzemann, R ^b   Angrist, B ^c   Lieberman, J ^d  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

Adaptation; Dopamine transporter; Methylphenidate; Pharmacokinetics; Positron emission tomography

Indexed keywords

CARBON 11; METHYLPHENIDATE;

ADULT; ANXIETY; ARTICLE; BASAL GANGLION; BEHAVIOR; BRAIN; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE TIME EFFECT RELATION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG UPTAKE; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOOD; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESTLESSNESS; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; BRAIN; HEART RATE; HUMANS; MALE; METHYLPHENIDATE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030054189     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246277     Document Type: Article

References (56)

1. Angrist B, Lee HKP, Gershon S (1974) The antagonism of amphetamine-induced symptomatology by a neuroleptic. Am J Psychiatry 131:817-819
2. Angrist B, Rotrosen J, Gershon S (1980) Response to apomorphine, amphetamine and neuroleptics in schizophrenia subjects, psychopharmacology 67:31-38
3. Aoyama T, Kotaki H, Sawada Y, Iga T (1994) Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites. Pharm Res 11:407-411
4. Blaster RL, Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effects of dose and infusion duration. J Exp Anal Behav 20:119-129
5. Bergman J, Madras B, Johnson SE, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155
6. Calligaro DO, Eldefrawi ME (1987) Central and peripheral cocaine receptors. J Pharmacol Exp Ther 243:61-68
7. Carroll FI, Lewin AH, Boja JW, Kuhar MJ (1992) Cocaine receptor: biochemical characterization and structure-activity relationship to cocaine analogues at the dopamine transporter. J Med Chem 35:969-981
8. Chait LD (1994) Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol 5:281-288
9. Chait LD, Uhlenhuth EH, Johanson CE (1986) The discriminative stimulus and subjective effects of phenylpropanolamine, muzindol and d-amphetamine in humans. Pharmacol Biochem Behav 24:1665-1672
10. Chait LD, Uhlenhuth EH, Johanson CE (1987) Reinforcing and subjective effects of several anorectics in normal human volunteers. J Pharmacol Exp Ther 242:777-783
11. Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR (1992) Noradrenergic neuronal dysregulation in patients with panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand 86: 73-282
12. Cook EC, Jeffcoat RA, Brine DR (1984) Metabolism and pharmacokinetics of drugs. Contract No. 271-80-3705 to NIDA. Research Triangle Institute, North Carolina, pp 141-147
13. Corwin RL, Woolverxton WL, Schuster CR, Johanson CE (1987) Anorectics: effects on food intake and self administration in rhesus monkeys. Alcohol Drug Res 7:351-361
14. de Wit H, Uhlenhuth EH, Johanson CE (1986) Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16:341-360
15. Deminiere IM, Piazza PV, Le Moal M, Simon H (1989) Experimental approach to individual vulnerability to psychostimulant addiction. Neurosci Biobehav Rev 13:141-147
16. Depue RA, Luciana M, Arbisis P, Collins P, Leon A (1994) Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J Person Soc Psychol 67:485-498
17. Deutch AY, Clark WA, Roth RH (1990) Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res 521:311-315
18. 11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron Synapse 18:152-160
19. Fischman MW, Schuster CR (1981) Cocaine self administration in humans. Fed Proc 41:241-246
20. Foltin RW, Fischman MW (1991) Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257:247-261
21. Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor R, Hitzemann R, Logan J, Bendriem B, Gatley J, Christman D (1989) Mapping cocaine-binding sites in human and baboon brain in vivo. Synapse 4:371-377
22. Fowler JS, Wolf AP, Volkow ND (1990) New directions in positron emission tomography- part II In: Allen RC (ed) Annual reports in medicinal chemistry. Academic Press, New Jersey, pp 261-269
23. Glassman AHS, Stetner F, Walsh T, Raizman PS, Leiss JI, Cooper TB, Covey LS (1988) Heavy smokers, smoking cessation and clonidine. JAMA 2259:2863-2866
24. Grace AA (1995) The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drugs Alcohol Depend 37:115-129
25. Janowsky DS, El-Yousef MK, Davis JM, Sekerke J (1973) Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry 28:185-192
26. Johanson CE, Fischmann M W (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3-52
27. Joyce PR, Donald RA, Nicholls MG, Lievesey JH, Abbott RM (1986) Endocrine and behavioral responses to methylphenidate in normal subjects. Biol Psychiatry 21:1015-1023
28. Kavoussi RJ, Coccaro E (1993) The amphetamine challenge test correlates with affective liability in healthy volunteers. Psychiatry Res 48:219-228
29. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723
30. Lieberman JA, Alvir J, Geisler S, Ramos-Lorenzi J, Woerner M, Novacenko H, Cooper T, Kane JM (1994) Methylphenidate response, psychopathology and tardive diskinesia as predictors of relapse in schizophrenia. Neuropsychopharmacology 11: 107-118
31. 11C-methyl-(-) cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740-747
32. 11C] raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995-1010
33. Madras BK, Kaufman MJ (1994) Cocaine accumulates in dopamine-rich regions of primate brain after IV administration: comparison with mazindol distribution. Synapse 18:261-275
34. 3C] cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141
35. Oldendorf WH (1992) Some relationships between addiction and drug delivery to the brain. In Frankenheim J, Brown RM (eds) bioavailability of drugs to the brain and blood brain barrier. Research Monograph 120, National Institue on Drug Abuse. Rockville, pp 13-25
36. Parran TV, Jasinski DR (1991) Intravenous methylphenidate abuse. Prototype for prescription drug abuse. Arch Int Med 151: 781-783
37. Patrick KS, Caldwell RW, Ferris RM, Breese GR (1987) Pharmacology of the enantiomers of threo-methylphenidate. J Pharmacol Exp Ther 241:152-158
38. Perez-Reyes M, DiGuiseppi S, Ondrusek G, Jeffcoat A, Cook CE (1982) Free-base cocaine smoking. Clin Pharmacol Ther 32:459-465
39. Redmond DE, Huang YH (1979) New evidence for a locus coeruleus norepinephrine connection with anxiety. Life Sci 25: 2149-2162
40. 3H] cocaine binding in brain is associated with serotonergic neurons. Mol Pharmacol 23:600-606
41. Richelson B, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277-286
42. Rtz MC, Lamb RJ, Goldeberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to the self-administration of cocaine. Science 237:1219-1223
43. Schindler CW, Tella SR, Erzouki HK, Goldberg SR (1995) Pharmacological mechanisms in cocaine's cardiovascular effects. Drug Alcohol Depend 37:183-191
44. Sherer MA, Kumor KM, Jaffe JH (1989) Effects of intravenous cocaine are partially attenutated by haloperidol. Psychiatry Res 27:117-125
45. 3H]Threo -(±)-methylphenidate uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J Neurochem 45:1062-1070
46. Seeman P (1993) Receptor tables. Vol 2. Drug dissociation for neuroreceptors and transporters. Sz Research, Toronto
47. Srinivas NR, Hubbard JW, Quinn D, Korchinski ED, Midha KK (1991) Extensive and enantioselective prcsystemic metabolism of dl-threo-methylphenidate in humans. Prog Neuro Psychopharmacol Biol-Psychiatry 5:213-220
48. Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll IF, Kuhar MJ (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology (in press)
49. Van Kammen D, Bunney WE, Docherty JP, Marder SR, Ebert MH, Rosenblatt JE, Rayner JN (1982) d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia. Am J Psychiatry 139:991-997
50. Verebey K, Gold MS (1988) From coca leaves to crack: the effects of dose and routes of administration in abuse liability. Pscyhiatr Ann 18:513-520
51. 11C-cocaine in human heart, lungs, liver and adrenals. A dynamic PET study. J Nucl Med 33:521-525
52. 11C]raclopride in the human brain. Synapse 16:255-262
53. Volkow ND, Ding U, Fowler JS, Wang G-J, Logan J, Gatley JS, Dewey SL, Ashby C, Lieberman J, Hitzemann R, Wolf AP (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 52:456-463
54. Von Felsinger JM, Lasagna L, Beechcr HK (1995) Drug-induced mood changes in man. 2. Personality and reactions to drugs. JAMA 157:1113-1119
55. Wang G-J, Volkow ND, Hitzemann R, Wong C, Angrist B, Burr G, Pascani K, Pappas N, Lu A, Cooper T, Lieberman J (1995) Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur Addict Res (in press)
56. Wilens TE, Biederman J (1992) The stimulants. Pediatr Psychopharmacol 15:191-222